97 related articles for article (PubMed ID: 1988187)
1. Enhanced hydroperoxide production by peripheral blood leukocytes following exposure of murine epidermis to 12-O-tetradecanoylphorbol-13-acetate.
Sirak AA; Beavis AJ; Robertson FM
Carcinogenesis; 1991 Jan; 12(1):91-5. PubMed ID: 1988187
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion.
Robertson FM; Bijur GN; Oberyszyn AS; Pellegrini AE; Boros LG; Sabourin CL; Oberyszyn TM
Carcinogenesis; 1994 May; 15(5):1017-29. PubMed ID: 8200063
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage.
Wei L; Wei H; Frenkel K
Carcinogenesis; 1993 May; 14(5):841-7. PubMed ID: 8389253
[TBL] [Abstract][Full Text] [Related]
4. Production of hydrogen peroxide by murine epidermal keratinocytes following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Robertson FM; Beavis AJ; Oberyszyn TM; O'Connell SM; Dokidos A; Laskin DL; Laskin JD; Reiners JJ
Cancer Res; 1990 Sep; 50(18):6062-7. PubMed ID: 2393871
[TBL] [Abstract][Full Text] [Related]
5. Comparative histomorphometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents.
Baxter CS; Andringa A; Chalfin K; Miller ML
Carcinogenesis; 1989 Oct; 10(10):1855-61. PubMed ID: 2791204
[TBL] [Abstract][Full Text] [Related]
6. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters.
Wei H; Frenkel K
Carcinogenesis; 1993 Jun; 14(6):1195-201. PubMed ID: 8508507
[TBL] [Abstract][Full Text] [Related]
7. Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
Molloy CJ; Laskin JD
Cancer Res; 1987 Sep; 47(17):4674-80. PubMed ID: 2441853
[TBL] [Abstract][Full Text] [Related]
8. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
Takigawa M; Simsiman RC; Boutwell RK
Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part II: Quantitation of glutathione and glutathione disulfide.
Reiners JJ; Kodari E; Cappel RE; Gilbert HF
Carcinogenesis; 1991 Dec; 12(12):2345-52. PubMed ID: 1747938
[TBL] [Abstract][Full Text] [Related]
10. Identification of epidermal cell subpopulations with increased ornithine decarboxylase activity following treatment of murine epidermis with 12-O-tetradecanoylphorbol-13-acetate.
Robertson FM; Gilmour SK; Conney AH; Huang MT; Beavis AJ; Laskin JD; Hietala OA; O'Brien TG
Cancer Res; 1990 Aug; 50(15):4741-6. PubMed ID: 2369749
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment.
Aldaz CM; Conti CJ; Gimenez IB; Slaga TJ; Klein-Szanto AJ
Cancer Res; 1985 Jun; 45(6):2753-9. PubMed ID: 3986807
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the hydroperoxide response observed in mouse skin treated with tumor promoters in vivo.
Perchellet EM; Perchellet JP
Cancer Res; 1989 Nov; 49(22):6193-201. PubMed ID: 2509065
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of sn-1,2-didecanoylglycerol and 12-O-tetradecanoylphorbol-13-acetate on cutaneous morphology, inflammation and tumor promotion in CD-1 mice.
Smart RC; Huang MT; Monteiro-Riviere NA; Wong CQ; Mills KJ; Conney AH
Carcinogenesis; 1988 Dec; 9(12):2221-6. PubMed ID: 3191568
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents.
Naito M; Naito Y; DiGiovanni J
Carcinogenesis; 1987 Dec; 8(12):1807-15. PubMed ID: 3119244
[TBL] [Abstract][Full Text] [Related]
16. Modulation of natural killer activity by 12-O-tetradecanoylphorbol-13-acetate and benzoyl peroxide in phorbol ester-sensitive (SENCAR) and resistant (B6C3F1) mice.
Updyke LW; Chuthaputti A; Pfeifer RW; Yim GK
Carcinogenesis; 1988 Nov; 9(11):1943-51. PubMed ID: 2972416
[TBL] [Abstract][Full Text] [Related]
17. Critical comparison of histological and morphometric changes in SENCAR mouse epidermis in response to n-dodecane, 12-O-tetradecanoylphorbol-13-acetate and mezerein.
Miller ML; Andringa A; Baxter CS
Carcinogenesis; 1988 Nov; 9(11):1959-65. PubMed ID: 3180333
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: a possible mechanism of antipromotion.
Wei H; Frenkel K
Cancer Res; 1992 Apr; 52(8):2298-303. PubMed ID: 1559232
[TBL] [Abstract][Full Text] [Related]
19. Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate.
Gilmour SK; Robertson FM; Megosh L; O'Connell SM; Mitchell J; O'Brien TG
Carcinogenesis; 1992 Jan; 13(1):51-6. PubMed ID: 1733573
[TBL] [Abstract][Full Text] [Related]
20. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin.
Wei H; Frenkel K
Cancer Res; 1991 Aug; 51(16):4443-9. PubMed ID: 1868465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
